JeanMarie Guenot has a desire to build companies. Her background starts twenty years ago with a mix of both the technical and the business side. She was a principle scientist at Hoffman-La Roche where she developed drugs for various conditions, specifically for metabolic diseases, oncology and autoimmune diseases. LinkedIn paints a picture of a JeanMarie Guenot that is a highly trained individual gaining her Ph.D. from the University of California, San Francisco. Even through her college years, she learned how to build medications, using physics to incorporate into drug design and molecular dynamics. This was the bulk of her training and experience in the technical side.
As is with natural progression, her website indicates JeanMarie transitioned into the business side taking her experience and using it for what the consumer is looking for. She worked at Atlas Venture where she worked with venture capitalists to build science companies. This will be the path she continues on designing and discovering different drugs that will help people. Another milestone in her career was founding SKS Ocular, where they developed ocular drug delivery techniques among other eye related issues. Currently, she works for Amphivena Therapeutics as their President and CEO. The company is “developing innovative bifunctional antibody therapies for hematologic malignancies.” Amphivena Therapeutics are developing an antigen for blood cancer and evaluating many areas which have medical needs.
The journey she has been over the years has been a benefit for generations to come. “Restoring the flow of life” is a phrase used at Amphivena Therapeutics. The research and development ongoing with this brain trust is to help the greater good from blood cancers, catching it before the illness develops too far. This is a great endeavor, even though results are time-consuming and difficult to come by. She continues to invest and build in companies for the greater good. Her collaborative outlook and the partnerships she builds in conjunction with her dynamic leadership team leads to another successful company building process.